<- Go Home
Nyxoah SA
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Market Cap
EUR 119.2M
Volume
68.0K
Cash and Equivalents
EUR 30.0M
EBITDA
-EUR 82.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 6.3M
Profit Margin
63.13%
52 Week High
EUR 8.87
52 Week Low
EUR 2.35
Dividend
N/A
Price / Book Value
2.39
Price / Earnings
-1.15
Price / Tangible Book Value
2.41
Enterprise Value
EUR 113.3M
Enterprise Value / EBITDA
-1.40
Operating Income
-EUR 83.4M
Return on Equity
110.95%
Return on Assets
-37.67
Cash and Short Term Investments
EUR 48.0M
Debt
EUR 42.1M
Equity
EUR 49.1M
Revenue
EUR 10.0M
Unlevered FCF
-EUR 42.2M
Sector
Health Care Equipment and Supplies
Category
N/A